Keyphrases
B-cell Lymphoma 2 (Bcl-2)
100%
Bcl-2 Family Proteins
100%
Therapy Response
100%
Astrocytic Glioma
100%
Glioblastoma
50%
Radiation Therapy
50%
Glioblastoma multiforme
50%
Therapy Resistance
50%
Molecular Mechanism
25%
Cancer Types
25%
Targeted Therapy
25%
Receptor Tyrosine Kinase
25%
Temozolomide
25%
Normal Brain
25%
Drug Development
25%
Recent Advances
25%
Angiogenesis
25%
Induced Apoptosis
25%
Neurosurgery
25%
Tumor Recurrence
25%
Salvage Therapy
25%
Patient Survival
25%
Median Survival
25%
Alkylating Agents
25%
Development Effort
25%
Necrosis
25%
Proliferative Index
25%
Highly Aggressive
25%
Malignant Glioma
25%
Induced Cell Death
25%
Brain Cancer
25%
Brain Parenchyma
25%
Moderate Resolution Imaging Spectroradiometer (MODIS)
25%
Soaring
25%
Medicine and Dentistry
Treatment Response
100%
Protein Family
100%
Glioblastoma
100%
Ganglioglioma
100%
Neoplasm
40%
Clinical Study
40%
Therapy Resistance
40%
Protein Bcl 2
40%
Radiation Therapy
40%
Malignant Neoplasm
20%
Cell Death
20%
Targeted Therapy
20%
Protein Tyrosine Kinase
20%
Angiogenesis
20%
Programmed Cell Death
20%
Adenosine Triphosphate
20%
Parenchyma
20%
Temozolomide
20%
Neurosurgery
20%
Tumor Recurrence
20%
Salvage Therapy
20%
Alkylating Antineoplastic Agent
20%
Necrosis
20%
Brain Cancer
20%
Neuroscience
Protein Family
100%
Bcl-2
100%
Protein Bcl 2
66%
Radiation Therapy
66%
Cell Death
33%
Receptor Tyrosine Kinase
33%
Adenosine Triphosphate
33%
Neurosurgery
33%
Angiogenesis
33%
Necrosis
33%
Parenchyma
33%
Alkylating Antineoplastic Agent
33%
Brain Cancer
33%
Proliferative Index
33%
Temozolomide
33%
Programmed Cell Death
33%
Pharmacology, Toxicology and Pharmaceutical Science
Glioblastoma
100%
Neoplasm
40%
Clinical Study
40%
Therapy Resistance
40%
Protein Bcl 2
40%
Malignant Neoplasm
20%
Temozolomide
20%
Protein Tyrosine Kinase
20%
Drug Development
20%
Adenosine Triphosphate
20%
Alkylating Agent
20%
Preclinical Study
20%
Tumor Recurrence
20%
Necrosis
20%
Brain Cancer
20%